The Second Breast Cancer Doctors Are Rethinking: New Insights on Risk, Prevention and Survival
A new review synthesizes declining contralateral breast cancer incidence, evolving risk prediction models, the biology of second primary tumors, and ...
A new review synthesizes declining contralateral breast cancer incidence, evolving risk prediction models, the biology of second primary tumors, and ...
A retrospective study of nearly 1,600 patients finds that HER2-low breast cancer behaves like HER2-0 disease in metastatic timing and ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine